Skip to Main content Skip to Navigation
Journal articles

Tacrolimus pommade dans la prise en charge de la kératoconjonctivite atopique

Abstract : Introduction: Atopic keratoconjunctivitis is associated with eyelid eczema. It may require the use of local corticosteroids which if prolonged can be a source of ocular complications. Tacrolimus is an immunosuppressant used in cutaneous application in atopic dermatitis. The aim of this study was to measure the efficacy and tolerance of tacrolimus 0.1% ointment in palpebral application in atopic keratoconjunctivitis.
Patients and methods: This retrospective, single-center study was conducted between June 2014 and February 2017. Patients with atopic keratoconjunctivitis not controlled by first-line medical treatments were included. The primary endpoint was the evolution of functional signs as assessed by the NEI-VFQ25 and OSDI quality of life scores. Secondary endpoints were visual acuity and local corticosteroid use.
Results: Among the 18 patients included, the mean age was 37.9 ± 16.8 years. The first follow-up visit was on average 68.3 ± 55.3 days after initiation of treatment. The NEI-VFQ25 score was significantly improved for seven of its sub-scores (P < 0.05) and the mean OSDI decreased significantly from 52.3 ± 26.2 to 22.0 ± 27.0 (P < 0.001) showing a decrease in eye discomfort. A significant reduction was observed in the number of patients using local corticosteroids. There was no significant change in visual acuity.
Conclusion: Tacrolimus ointment 0.1% in palpebral application appears to be an effective treatment for the management of atopic keratoconjunctivitis.
Document type :
Journal articles
Complete list of metadata
Contributor : Accord Elsevier Ccsd Connect in order to contact the contributor
Submitted on : Friday, October 22, 2021 - 8:53:57 PM
Last modification on : Wednesday, November 3, 2021 - 6:12:54 AM


Files produced by the author(s)


Distributed under a Creative Commons Attribution - NonCommercial 4.0 International License



D. Benaim, F. Tetart, O. Bauvin, A. Delcampe, P. Joly, et al.. Tacrolimus pommade dans la prise en charge de la kératoconjonctivite atopique. Journal Français D'Ophtalmologie, Elsevier Masson, 2019, 42 (5), pp.435-440. ⟨10.1016/j.jfo.2018.07.018⟩. ⟨hal-02316561⟩



Les métriques sont temporairement indisponibles